• Auxilium Pharmaceuticals (NASDAQ:AUXL) posted a Q2 loss of $0.11 per share, less than the analysts’ estimate for a loss of $0.19 per share. Revenues for the quarter increased 30.5% year-over-year to $65.9 million
• Humana (NYSE:HUM) reported Q2 EPS of $2.50, beating the Zacks Consensus Estimate of $2.07 per share. Revenues increased 8.1% year-over-year to $9.28 billion, lower than the Zacks Consensus Estimate of $9.32 billion
• Acorda Therapeutics (NASDAQ:ACOR) posted Q2 EPS of $0.01. Revenues for the pharma company rose 52.6% year-over-year to $65.3 million
• Share prices of Old National Bancorp. (NYSE:ONB) gained 7.25% after the bank-holding company posted second quarter earnings results that came in above expectations
• PAETEC Holding Corp (NASDAQ:PAET) agreed to be acquired by Windstream Corp for a deal valued at $891 million. Reacting to the news, shares of PAETEC increased 20.59%
• Share prices of blood-processing device maker, Haemonetics Corp. (NYSE:HAE) fell 10.90% after the company lowered its earnings forecast for the 2011 fiscal
• Analysts at Jefferies upgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) to “Buy” rating from “Hold” rating and also increased the target price of the company to $52 from $29
• Shares of Key Energy (NYSE:KEG) were upgraded by Weeden to “Buy” rating from “Hold” rating with a target price of $26.00
